Are you expecting that Prana would ever have any interest in preventing thromboemboli related to thalassemia thereby wasting their assets even more? It's difficult to understand how PD or movement disorders or whatever is left in Prana's library would be pushed aside to start with another brand new diagnosis. It won't happen, as so many hopeful concepts that are brought to attention here by someone else's abstracts do not happen.
This is the issue of the day/month/year: We now know thatPBT434 will not enter a Phase I clinical trial this year. Maybe this time Prana is following FDA's trial recommendations before jumping into a clinical trial and then years later finding themselves unable to complete it. I can't think of any other reason. Can anyone else?
- Forums
- ASX - By Stock
- ATH
- Deferiprone can protect mitochondrial injury
Deferiprone can protect mitochondrial injury, page-2
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $20.98M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $298 | 74.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
55 | 69476657 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 20550793 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 180675 | 0.006 |
2 | 360000 | 0.005 |
57 | 74205657 | 0.004 |
52 | 57637564 | 0.003 |
15 | 37493014 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 722700 | 1 |
0.005 | 29515102 | 13 |
0.006 | 16574598 | 22 |
0.007 | 17174670 | 18 |
0.008 | 14585875 | 16 |
Last trade - 13.22pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
0.4¢ |
  |
Change
-0.001 ( 11.1 %) |
|||
Open | High | Low | Volume | ||
0.4¢ | 0.4¢ | 0.4¢ | 100000 | ||
Last updated 11.49am 05/06/2024 ? |
Featured News
ATH (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online